News

Our Healthcare News

Entellus Medical, Inc. Announces Pricing of Initial Public Offering

PLYMOUTH, Minnesota—Entellus Medical, Inc., a medical technology company focused on products for the minimally invasive treatment of chronic and recurrent sinusitis patients in the physician…  

Jan 28 2015

Abiomed Receives FDA HDE Approval for the Impella RP

First FDA Approved Percutaneous Single Access Heart Pump Designed for Right Heart Support

DANVERS, MA –  Abiomed Inc. (NASDAQ: ABMD), a leading provider of…  

Jan 27 2015

Revance Therapeutics Announces Publication of Positive Results from RT002 Phase 1/2 Study

NEWARK, California—(GLOBE NEWSWIRE)—Revance Therapeutics, Inc. (Nasdaq:RVNC), a specialty biopharmaceutical company developing botulinum toxin products for the use in aesthetic and therapeutic indications, today announced publication…  

Jan 08 2015

Revance Therapeutics Added to NASDAQ Biotechnology Index

NEWARK, California—Revance Therapeutics, Inc. (NASDAQ:RVNC), a specialty biopharmaceutical company developing botulinum toxin products for the use in aesthetic and therapeutic indications, announced today that it…  

Dec 18 2014

Endologix Completes Patient Enrollment in the Nellix EVAS FORWARD-IDE Clinical Trial

IRVINE, California—(GLOBE NEWSWIRE)—Endologix, Inc. (NASDAQ:  ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has completed patient enrollment in the…  

Nov 18 2014

PharMerica Acquires Millennium Pharmacy Systems

LOUISVILLE, Kentucky—PharMerica Corporation (NYSE: PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today announced that it has completed the…  

Sep 26 2014

Horizon Pharma Announces Stockholder Approval of Its Acquisition of Vidara Therapeutics

DEERFIELD, IL—Horizon Pharma, Inc. announced that at its Special Meeting of Stockholders held today, proposals related to Horizon’s acquisition of Vidara Therapeutics International plc were…  

Sep 18 2014

MEDSEEK to Become Influence Health

Birmingham, AL, September 17, 2014 – MEDSEEK today announced that it is changing the company name to “Influence Health” to reflect its ongoing success in…  

Sep 17 2014

Teva’s Well-Traveled Asthma Drug Comes Through in Phase III

Teva ($TEVA) is inching toward an FDA application for reslizumab, touting positive late-stage results for an asthma antibody passed around for years in multiple buyouts.

 

Sep 03 2014